The “<i>David Vs Goliath</i>” Study: Application of Large Language Models (LLM) for Automatic Medical Information Retrieval from Multiple Data Sources to Accelerate Clinical and Translational Research in Hematology
Mattia Delleani(IRCCS Humanitas Research Hospital), Matteo Giovanni Della Porta(Humanitas University), Rami S. Komrokji(Moffitt Cancer Center), Saverio D’Amico(Humanitas University), Luca Di Tommaso(Humanitas University), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Gastone Castellani(University of Bologna), Marilena Bicchieri(Humanitas University), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Shahram Kordasti(Guy's Hospital), Gabriele Todisco(Humanitas University), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Daoud Rahal(IRCCS Humanitas Research Hospital), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Amer M. Zeidan(Yale Cancer Center), Alejandro F. Barrero(Humanitas University), Marta Ubezio(Humanitas University), Maria Chiara Grondelli(Istituti di Ricovero e Cura a Carattere Scientifico), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pierandrea Morandini(IRCCS Humanitas Research Hospital), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Arturo Bonometti(Humanitas University), Giulia Maggioni(Humanitas University), Luca Lanino(Humanitas University), Valeria Santini(University of Florence), Gianluca Asti(IRCCS Humanitas Research Hospital), Alessandro Buizza(Istituti di Ricovero e Cura a Carattere Scientifico), Elena Zazzetti(IRCCS Humanitas Research Hospital), Armando Santoro(IRCCS Humanitas Research Hospital), Antonio Russo(Humanitas University), Elisabetta Sauta(Humanitas University), Pierre Fenaux(Assistance Publique – Hôpitaux de Paris), Cesare Lancellotti(Azienda Ospedaliero-Universitaria di Modena)
Cited by 1
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821